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BACKGROUND AND PURPOSE
Ethanol is a widely used recreational drug with complex effects on physiological and pathological brain function. In epileptic
patients, the use of ethanol can modify seizure initiation and subsequent seizure activity with reports of ethanol being both pro-
and anticonvulsant. One proposed target of ethanol’s actions is the neuromodulator adenosine, which is released during epileptic
seizures to feedback and inhibit the occurrence of subsequent seizures. Here, we investigated the actions of acute ethanol
exposure on adenosine signalling in rat hippocampus.
EXPERIMENTAL APPROACH
We have combined electrophysiology with direct measurements of extracellular adenosine using microelectrode biosensors in rat
hippocampal slices.
KEY RESULTS
We found that ethanol has bidirectional actions on adenosine signalling: depressant concentrations of ethanol (50mM) increased
the basal extracellular concentration of adenosine under baseline conditions, leading to the inhibition of synaptic transmission,
but it inhibited adenosine release during evoked seizure activity in brain slices. The reduction in activity-dependent adenosine
release was in part produced by effects on NMDA receptors, although other mechanisms also appeared to be involved. Low
concentrations of ethanol (10–15 mM) enhanced pathological network activity by selectively blocking activity-dependent
adenosine release.
CONCLUSIONS AND IMPLICATIONS
The complex dose-dependent actions of ethanol on adenosine signalling could in part explain the mixture of pro-convulsant and
anticonvulsant actions of ethanol that have previously been reported.
Abbreviations
ADO, biosensor adenosine biosensor; ENT, equilibrative nucleoside transporter; INO, biosensor inosine biosensor
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Introduction
Ethanol has complex effects on brain function, which are
still not fully understood. In low doses, ethanol can be an
excitant whereas in higher doses, it is a depressant (for review,
see Hendler et al., 2013). These contradictory effects have also
been observed in patients with epilepsy, as ethanol can act as
an anticonvulsant (Fischer, 2005) but can also be pro-
convulsant (Cohen et al., 1993; reviewed in Leach et al.,
2012) in particular leading to the relapse of patients who are
stabilized by medication (Gordon and Devinsky, 2001). The
mechanisms of ethanol’s effect on network activity at the
cellular and molecular level are still not fully characterized
and may differ depending on brain region (see Harrison
et al., 2017 for review). For a long period, ethanol was
believed to exert its effects by producing a general depression.
However, it has become increasingly clear that ethanol
interacts with a number of speciﬁc neurotransmitter systems
including GABA (where it enhances the GABAA receptor
conductance in a concentration-dependent manner, Förstera
et al., 2016) and glutamate (Möykkynen and Korpi, 2012),
interacts with speciﬁc voltage-gated channels (e.g. BK
channels, Bettinger and Davies, 2014; Ca2+ channels,
Walter and Messing, 1999) and can also directly modify cell
membrane function (Fleuret-Balter et al., 1983). All of these
effects could potentially change the threshold for seizures
and modify seizure duration.
It was postulated over 30 years ago that ethanol could
produce some of its effects by interacting with adenosine
signalling mechanisms (ﬁrst suggested by Dar et al., 1983,
and reviewed in Mailliard and Diamond, 2004; Ruby et al.,
2010; Nam et al., 2013). In particular, there is strong
evidence that ethanol can increase the extracellular concen-
tration of adenosine in the brain (Sharma et al., 2010), and
some of the effects of ethanol can be reduced by adenosine
receptor antagonists (Franks et al., 1975). Adenosine is a po-
tent neuromodulator involved in many physiological and
pathological processes (reviewed in Dunwiddie and Masino,
2001; Sebastião and Ribeiro, 2009; Borea et al., 2016).
Adenosine acts via multiple cell-surface GPCRs, with the
high-afﬁnity inhibitory A1 receptor being the most widely
expressed (reviewed in Fredholm et al., 2000). Presynaptic
A1 receptors inhibit the release of neurotransmitters (ﬁrst
discovered by Vizi and Knoll, 1976), and A1-receptor activa-
tion also hyperpolarizes neuronal membranes. Adenosine
can be released into the extracellular space by a number of
mechanisms: directly via equilbrative nucleoside trans-
porters (ENTs, Lovatt et al., 2012; Wall and Dale, 2013) as
ATP from neurons (Pankratov et al., 2007) or glial cells
(Newman, 2004; Pascual et al., 2005; Wall and Dale, 2013)
and then metabolized in the extracellular space, or adeno-
sine can be released directly as a neurotransmitter (Klyuch
et al., 2012). During epileptic seizures, adenosine is released
into the extracellular space to activate A1 receptors to termi-
nate bursts of activity and to delay or prevent the onset of
the next seizure (During and Spencer, 1992; Dale and
Frenguelli, 2009; Wall and Richardson, 2015). In hippocam-
pal and neocortical slices, adenosine release during epilepti-
form activity has been directly measured and characterized
with microelectrode biosensors (Frenguelli and Wall, 2015;
Wall and Richardson, 2015).
In the present study, we used a combination of electro-
physiology and microelectrode biosensors to produce the
ﬁrst direct characterization of the effects of acute ethanol
exposure on adenosine signalling during epileptiform activ-
ity. In most experiments, we used 50 mM ethanol, which is
a concentration that can be measured in the blood stream of
heavy drinkers (reviewed in Harrison et al., 2017). We found
that ethanol has contradictory effects, enhancing the basal
concentration of adenosine but also inhibiting the release of
adenosine during seizure activity. These effects may help to
explain the pro- and anticonvulsant effects of ethanol that
have been reported previously.
Methods
Preparation of hippocampal slices
All animal care and experimental procedures were reviewed
and approved by the institutional animal welfare and ethical
review body (University of Warwick). Animal studies are re-
ported in compliance with the ARRIVE guidelines (Kilkenny
et al., 2010; McGrath and Lilley, 2015).
Sagittal slices of hippocampus (400 μm) were prepared
frommale Sprague Dawley rats, at postnatal days 20–30 (Wall
and Dale, 2013). Rats were kept on a 12 h light–dark cycle
with slices made from rats killed 90 min after entering the
light cycle. In accordance with the U.K. Animals (Scientiﬁc
Procedures) Act (1986), male rats were killed by cervical
dislocation and decapitated. The brain was removed, cut
down the mid line and the two sides of the brain stuck down
to the base plate. Slices were cut around the midline with a
Microm HM 650 V microslicer in cold (2–4°C) high Mg2+,
low Ca2+ aCSF, composed of (mM): 127 NaCl, 1.9 KCl, 8
MgCl2, 0.5 CaCl2, 1.2 KH2PO4, 26 NaHCO3, 10 D-glucose
(pH 7.4 when bubbled with 95% O2 and 5% CO2, 300
mOsm). Slices were stored at 34°C for 1–6 h in aCSF (1 mM
MgCl2, 2 mM CaCl2) before use.
Extracellular and biosensor recording from
hippocampal slices
A slice was transferred to the recording chamber, submerged
in aCSF and perfused at 4–6 mL·min1 (32°C); the slice was
placed on a grid allowing perfusion above and below the
tissue, and all tubing was gas tight (to prevent loss of oxygen).
For extracellular recording, an aCSF ﬁlled microelectrode was
placed on the surface of stratum radiatum in CA1. Extracellu-
lar recordings were made using a differential model 3000
ampliﬁer (AM systems, WA, USA) with ﬁeld EPSPs (fEPSPs)
and adenosine release evoked with an isolated pulse
stimulator model 2100 (AM Systems, WA). For fEPSPs, a
10–20 min baseline was recorded at a stimulus intensity that
gave 40–50% of themaximal response. Signals were ﬁltered at
3 kHz and digitized on line (10 kHz) with a Micro CED (Mark
2) interface controlled by Spike software (Vs 6.1, Cambridge
Electronic Design, Cambridge, UK). For fEPSP slope, a 1 ms
linear region after the ﬁbre volley was measured. Standard
cylindrical microelectrode biosensors were inserted into the
slice, so that biosensors went through the slice in stratum
radiatum in area CA1 (Wall and Dale, 2013). Slices were then
allowed to recover before measurements were made.
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Biosensor characteristics
Biosensors (Sarissa Biomedical Ltd, Coventry, UK) consist of
enzymes trapped within a matrix around a Pt or Pt/Ir (90/
10) wire (Llaudet et al., 2003). Biosensors were cylindrical
with an exposed length of ~500 μm and diameter of
~50 μm. Three types of sensor were used in this study: ﬁrstly,
null sensors, possessing the matrix but no enzymes, to
control for non-speciﬁc electro-active interferents; secondly,
biosensors containing adenosine deaminase, nucleoside
phosphorylase and xanthine oxidase (responsive to
adenosine, inosine and hypoxanthine: ADO biosensors);
and thirdly, biosensors containing nucleoside phosphorylase
and xanthine oxidase (responsive to inosine and hypoxan-
thine: INO biosensors).
A full description of biosensor properties has been
published previously (Llaudet et al., 2003); they show a linear
response to increasing concentrations of analyte and have a
fast response time (<1 s, Wall and Richardson, 2015). In each
experiment, the biosensors were calibrated with the analyte
(10 μM) before and after insertion in the slice, to check for
loss of sensitivity. An application of 10 μM 5-HT was used
to check that the screening layer was intact. In many of the
experiments, the composition of purines detected by ADO
biosensors was not fully deﬁned. Since ADO biosensors have
an equal sensitivity to adenosine, inosine and hypoxanthine
(Llaudet et al., 2003;Wall et al., 2007), the total concentration
of purines detected was related to the calibration to
adenosine to give μM’ or nM’ of purines (as outlined in
Pearson et al., 2001; Klyuch et al., 2011). For simplicity, we
refer to biosensor measurements as adenosine rather than
purines. Biosensor signals were acquired at 1 kHz with a
Micro CED (Mark 2) interface using Spike (Vs 6.1) software.
Measuring the effects of ethanol on adenosine
release during seizure activity
To determine the effects that acute ethanol exposure has on
adenosine release during seizure activity, seizure activity was
induced in hippocampal slices with zero Mg2+ aCSF with
50 μM 4-aminopyridine (4-AP) (reviewed in Frenguelli
and Wall, 2015). Adenosine release was monitored with an
adenosine biosensor (with the signal on the null sensor
subtracted). In most experiments, ethanol was applied at a
concentration of 50 mM. Experiments were done in two
ways: ﬁrstly, slices were pre-incubated in ethanol
(10–15 min) and then perfused with zero Mg2+ aCSF and
50 μm 4-AP (ethanol still present), and responses were
compared with interleaved slices where no ethanol was
applied. Secondly, seizure activity was established, and then
ethanol was applied.
Deconvolution and reconvolution of purine
waveforms
The amplitude of closely spaced waveforms produced by the
release of adenosine is difﬁcult to quantify accurately as sub-
sequent pulses sit on the decay and overlap with preceding
ones. Following Richardson and Silberberg (2008), closely
spaced release-events were deconvolved as in Klyuch et al.
(2011) by removing the long decay τo component. The
resulting sharper, well-spaced events were then cropped and
reconvolved (using the same decay constant) to yield isolated
waveforms from which the amplitude and rise time could be
accurately and straight forwardly measured (Wall and
Richardson, 2015; Frenguelli and Wall, 2015). All analyses
was done in the JULIA programming environment.
Statistical methods
All values are given as mean ± SEM. Statistical signiﬁcance
was tested with one-way ANOVA and Student’s paired or
unpaired t-tests. The data and statistical analysis comply with
the recommendations on experimental design and analysis
in pharmacology (Curtis et al., 2015).
Drugs
Drugs were made up as stock solutions (1–10 mM) and then
diluted in aCSF on the day of use. Drugs used: the NMDA
receptor antagonist L689560 (Tocris), the A1 receptor
antagonist 8-cyclopentyltheophylline (8CPT) (Sigma),
the equilibrative nucleoside transporter inhibitors NBTI
and dipyridamole (Sigma) and the non-selective glutamate
receptor antagonist kynurenate (Tocris). Ethanol was
directly added to the aCSF just before application to the slice.
Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked
to corresponding entries in http://www.guidetopharma-
cology.org, the common portal for data from the IUPHAR/
BPS Guide to PHARMACOLOGY (Harding et al., 2018), and
are permanently archived in the Concise Guide to PHARMA-
COLOGY 2017/18 (Alexander et al., 2017a,b,c,d).
Results
Ethanol does not affect biosensor sensitivity to
adenosine
We ﬁrst tested whether ethanol has effects on biosensor prop-
erties that could impair adenosine measurements. With no
tissue present, ethanol induced a concentration-dependent
(10–100mM) positive deﬂection (100–300 pA) in the baseline
current of the ADO biosensor (Figure 1A). Since this effect was
of a similar magnitude on the null sensor (which lacks the
detecting enzymes, Figure 1A), this suggests that ethanol
produces a direct electrochemical effect on the polarized
biosensor. By subtracting the current on the null sensor from
the ADO biosensor current, the effects of ethanol on the base-
line current could be removed (Figure 1A, B; n = 4). Ethanol
(10–100 mM) had no signiﬁcant effect on the sensitivity of
the biosensor to adenosine (Figure 1A, n = 4). Long applica-
tions of ethanol (up to 30 min, 50 mM) also had no effect
on biosensor sensitivity (n = 3, Figure 1C). Thus, ethanol does
not change the sensitivity of the biosensor, and the linear
increase in baseline current produced by ethanol can be
removed by subtracting the signal on the null sensor.
Ethanol can increase the basal extracellular
adenosine concentration
We ﬁrst tested whether acute ethanol application changes
the basal extracellular concentration of adenosine. An ADO
biosensor and null sensor were inserted into CA1, and
ethanol was applied. In the majority of slices (25 out of 40),
The actions of acute ethanol exposure on adenosine signalling
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the ethanol-induced upward shift in baseline current was the
same amplitude on the ADO biosensor as the null sensor (in
four cases, the signal on the null was slightly greater than
on the ADO biosensor), and thus, upon subtraction, there
was no net increase in current (Figure 2A). Thus, in these
slices, there is no detectable change in the extracellular
concentration of adenosine when ethanol was applied.
However, in 15 out of 40 hippocampal slices, 20–50 mM
ethanol induced a net signal on the ADO biosensor: the cur-
rent deﬂection on the ADO biosensor persisted after
subtracting the null sensor signal (mean current after
subtracting current on null sensor for 50 mM ethanol,
175 ± 30 pA, equivalent to ~0.8 μM’ of adenosine, Figure 2B).
This increase in baseline current on the ADO biosensor
could be observed with concentrations of ethanol above
20 mM and increased in amplitude as the concentration of
ethanol was increased (tested up to 50 mM). With repeated
applications, the amplitude of the current on the ADO bio-
sensor signiﬁcantly diminished (P < 0.05 one-way ANOVA),
unlike the current on the null sensor that remained at a
constant amplitude (Figure 2B, C) suggesting depletion of
adenosine stores. To test whether sufﬁcient adenosine was
released to inhibit synaptic transmission, fEPSPs were
recorded simultaneously with biosensor measurements. In
the slices where there was a net ADO biosensor current,
fEPSP slope was reduced (Figure 2D, n = 3) with a similar
time course to the biosensor current. In slices in which
there was no net ADO biosensor current, fEPSP slope was
unaffected by ethanol application (not illustrated n = 3).
In a further six slices, fEPSP was recorded without biosensor
measurements, ethanol decreased the initial slope of fEPSPs
(mean inhibition of fEPSPs with and without biosensor
measurements 30.8 ± 4.3%, n = 9 slices). In the six slices,
the inhibition could be reversed by blocking A1 receptors
with the antagonist 8CPT (2 μM 8CPT increased fEPSP slope
by 12 ± 3%, Figure 2E). The inhibition produced by ethanol
signiﬁcantly (P < 0.05, one-way ANOVA) increased paired
pulse facilitation (at short intervals 100 ms and less) consis-
tent with a change in neurotransmitter release probability
and the actions of adenosine at presynaptic A1 receptors
(Figure 2F, Dunwiddie and Haas, 1985). Differential mea-
surements with ADO and INO biosensors revealed a rapidly
rising transient signal upon subtraction that is consistent
with the direct detection of adenosine (Figure 2G, n = 4
out of 10 recordings, in the other six recordings, no clear
adenosine signal was discernible). This adenosine compo-
nent diminished with repeated ethanol applications.
Adenosine can be released by the activation of ionotropic
glutamate receptors (Wall and Dale, 2013). However, the
increase in extracellular adenosine concentration produced
by ethanol was not dependent on glutamate receptors as it
persisted in the presence of 5mM kynurenate, a non-selective
antagonist at NMDA and AMPA/kainate receptors
(Figure 2H, n = 5). Another possible mechanism is inhibition
of adenosine transporters. This does not seem likely as the
effects of ethanol were very rapid, unlike the effects of
blocking transporters (e.g. see Dunwiddie and Diao, 1994;
Frenguelli et al., 2007). Furthermore, the effects of ethanol
persisted in the presence of ENT inhibitors (NBTI and
dipyridamole n = 5, not illustrated).
Ethanol can reduce the basal continuous A1
receptor activation
We also observed that in a subset of slices, ethanol could
reversibly increase fEPSP slope (in nine slices, mean increase
in fEPSP slope 40.1 ± 6%, Figure 3 also observed in Diao and
Dunwiddie, 1996). This increase in fEPSP slope was
Figure 1
Effect of ethanol on biosensor properties. (A) Traces from an adeno-
sine biosensor (ADO), null sensor and the ADO biosensor (null
subtracted). Increasing concentrations of ethanol (10–50 mM) in-
duced an upward shift in the baseline current on both null and
ADO biosensor but had no effect on adenosine (10 μM) calibration
currents. Subtraction of the null trace from the ADO biosensor trace
removed the baseline shift. (B) Graph plotting the mean ratio of the
ethanol-induced current on ADO biosensor versus the null sensor
against ethanol concentration (three ADO biosensor and null sensor
pairs). (C) Trace from an ADO biosensor (null subtracted). Applica-
tion of ethanol (50 mM for 25 min) had no effect on biosensor sen-
sitivity to adenosine (10 μM).
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Figure 2
Ethanol increases extracellular adenosine concentration. (A) Example trace from an ADO biosensor (null subtracted) and null sensor that have
been placed in area CA1. Ethanol induced a shift in ADO baseline current, which was removed by null subtraction. No net increase in the
adenosine biosensor current was observed in 62% of slices. (B) Traces from an ADO biosensor (null subtracted) and null sensor. Ethanol
(50 mM) induced an upward shift in the ADO baseline current that persisted after null subtraction. This was the case for 38% of slices. (C) Graph
plotting the relative amplitude of currents induced by ethanol (50 mM) for ﬁrst and second applications measured on the null sensor and the ADO
biosensor (null subtracted). Currents were normalized to the amplitude of the current produced by the ﬁrst application of ethanol. (D) Graph
plotting fEPSP slope versus time for an individual slice. Ethanol (50 mM) reversibly decreased fEPSP slope. Inset, trace from an ADO biosensor (null
subtracted). (E) Graph plotting fEPSP slope against time for an individual slice. The effect of ethanol (50 mM) was blocked by the A1 receptor
antagonist 8CPT (2 μM). Inset, superimposed fEPSP averages in control and in ethanol. (F) Graph of paired pulse ratio against pulse interval in
control and in 50 mM ethanol. Ethanol signiﬁcantly increased the paired pulse ratio at short intervals (up to 100 ms but had no effect on intervals
at 200 and 500ms). (G) Superimposed current traces from an ADO and INO biosensor. Subtracting the scaled INO trace from ADO trace revealed
an adenosine current in response to 50 mM ethanol. (H) Trace from an ADO biosensor (null subtracted). The glutamate receptor antagonist
kynurenate (5 mM) did not prevent the ethanol (50 mM)-induced current.
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British Journal of Pharmacology (2018) 175 1471–1485 1475
accompanied by a signiﬁcant reduction in the paired pulse
ratio (for a 50 ms interval, reduced from 1.89 ± 0.05 to
1.77 ± 0.12, P < 0.05 one-way ANOVA, n = 6, Figure 3B) and
could be abolished by pre-incubation with 8CPT (n = 4 slices,
Figure 3A). Thus, the increase in fEPSP appears to stem from a
reduction in tonic A1 receptor activation. If ethanol reduces
the extracellular concentration of adenosine, we should be
able to observe a fall in the ADO biosensor current. As previ-
ously noted, we observed a small fall in the ADO-null current
in four slices out of 40 slices (the mean drop in current was
111 ± 20 pA, equivalent to ~0.4 μM). We predicted that if
the extracellular concentration of adenosine was low (little
network activity), ethanol would be unable to signiﬁcantly
increase fEPSP slope by reducing extracellular adenosine
concentration. In contrast, if the extracellular concentration
of adenosine was high, then the likelihood of ethanol
increasing fEPSP slope, by reducing adenosine concentration,
would be increased. To test this prediction, we compared the
effects of blocking A1 receptors (with 8CPT 2 μM) with the
effects of ethanol on fEPSP slope (ethanol was applied ﬁrst,
then washed off, then 8CPT was applied). There was signiﬁ-
cantly (P < 0.05, one-way ANOVA) greater A1 receptor
activation in slices when ethanol markedly increased fEPSP
slope compared with slices where ethanol had little or no ef-
fect on fEPSP slope (Figure 3C). This data suggest that ethanol
effects are bidirectional as it can increase or decrease A1 recep-
tor activation. The reason for such variability remains unclear
but may contribute to the reported complex effects of adeno-
sine on basal synaptic transmission in the hippocampus.
Ethanol modulates adenosine release during
electrographic seizure activity
We investigated whether ethanol modulated adenosine
release during electrographic seizure activity. In slices pre-
incubated in ethanol (see Methods), there was a reduction
in seizure-induced adenosine release. Figure 4 illustrates data
from two interleaved slices. Application of ethanol increased
the basal extracellular concentration of adenosine (upward
shift in baseline Figure 4B). Such an effect was observed in
three out of six slices, with no change in baseline in the other
three slices. There was no signiﬁcant change in the latency to
the ﬁrst burst of activity in control slices and slices treated
with ethanol. Signiﬁcantly less adenosine was released in
the pre-incubated slice compared with the control slice
(Figure 4D). In ethanol, the adenosine waveforms were of
signiﬁcantly (Figure 4E) shorter duration than in control,
which mirrored the duration of network bursts (Figure 4C).
This reduction in burst length may partly explain the fall in
adenosine release. Following ethanol wash, there was a
partial recovery with greater burst duration leading to more
adenosine release (Figure 4C). In some slices, pre-incubation
in ethanol altered seizure activity, so it was not isolated bursts
(Figures 4A, C) but was instead continual activity (Figure 4F,
n = 4 slices). Following wash, seizure activity reverted to
isolated bursts (Figure 4F).
When ethanol was applied during seizure activity (see
Methods), it had two clear effects (n = 10 slices): it inhibited
the release of adenosine, resulting in a fall in the biosensor
current (mean inhibition 65 ± 25% n = 6 slices, Figure 5A).
This was especially obvious when the adenosine release
pulses were separated by deconvolution (Figure 5A, decon).
In most slices (four out of six), this effect was partly reversible
upon wash (Figure 5A). Ethanol also changed the pattern of
network activity from separated bursts into continuous short
duration bursts or population spikes (Figure 5A, B) similar to
Figure 3
Ethanol can reduce basal A1 receptor continuous activation. (A)
Graph plotting fEPSP slope against time for an individual slice. Etha-
nol (50 mM) reversibly increased fEPSP slope, which was blocked by
the A1 receptor antagonist 8CPT (2 μM, the stimulus was reduced to
return the fEPSP slope to control values before ethanol was applied).
The gap in recording during the ﬁrst ethanol application is for paired
pulse recording. Inset, fEPSP averages in control, 50 mM ethanol and
in wash. (B) The paired pulse data taken from (A) showing that etha-
nol reduces the paired pulse ratio at short intervals (up to 100 ms)
but had little effect at longer intervals (n = 6). (C) Traces from an
ADO biosensor with the null subtracted, ADO biosensor and null sen-
sor. Ethanol (50 mM) induced a net downward shift in the ADO bio-
sensor with null subtracted consistent with a fall in the extracellular
concentration of adenosine. (D) Bar chart plotting the increase in
fEPSP slope produced by 8CPT separated into those slices where eth-
anol enhanced fEPSP slope and those slices where ethanol had little
effect (n = 9). *P< 0.05.
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Figure 4
Ethanol pre-incubation reduces adenosine release and changes seizure activity. Recordings from interleaved slices. (A) Control slice; ADO biosen-
sor trace (null subtracted) and extracellular trace. Seizure activity induced with zero Mg2+ and 50 μM 4-AP. (B) Slice was pre-incubated in 50 mM
ethanol before seizure activity. Ethanol induced an increase in the extracellular concentration of adenosine as shown by the upward shift in the
baseline. (C) Expanded trace from (B) with adenosine-release pulses deconvolved (time constant 560 s). Seizure activity increased extracellular
adenosine concentration in both slices, but markedly less adenosine was released in the pre-incubated slice (peak concentration after three bursts of ac-
tivity, control 1.5 vs. 0.2 μMethanol). This inhibition of adenosine release was partially reversed in wash with an increase in burst duration. (D) Bar-chart
summarizing peak concentrations of adenosine measured in control slices and slices incubated in ethanol (n = 6). (E) Bar chart summarizing mean burst
durationmeasured in control slices and slices incubated in ethanol (n = 6). (F) Extracellular recordings from two interleaved slices that were pre-incubated
in 50 mM ethanol. The induced activity was continuous and not in isolated bursts until ethanol was washed out. *P<0.05.
The actions of acute ethanol exposure on adenosine signalling
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the effects of blocking A1 receptors with a receptor antagonist
(e.g. see Wall and Richardson, 2015; Lopatář et al., 2015).
Again, this effect was reversible in some slices. The disruption
of network activity is consistent with the inhibition of
activity-dependent adenosine release and a fall in A1-receptor
activation.
Ethanol inhibits electrically stimulated
adenosine release
The effects of ethanol are difﬁcult to interpret; the ethanol-
induced fall in adenosine release could change network
activity or conversely an ethanol-induced change in network
activity could reduce adenosine release. To dissect these
mechanisms, we controlled network activity by electrically
stimulating in CA1 during lulls in activity or during periods
of low activity (lack of bursts) and found that ethanol still
decreased adenosine release (Figure 5A, D; mean inhibition
71 ± 23%, n = 4). However, ethanol may still modulate any
seizure activity induced by electrical stimulation, and thus,
we repeated stimulation in basal conditions. Trains of elec-
trical stimuli were delivered in CA1 (see Wall and Dale,
2013). In the majority of slices (12 out of 15 slices), etha-
nol (50 mM) signiﬁcantly (P < 0.05, one-way ANOVA)
inhibited adenosine release (Figure 6A, mean inhibition
66 ± 7%, n = 12). Adenosine release signiﬁcantly
(P < 0.05, one-way ANOVA) recovered in wash (93 ± 5%
recovery) and was concentration-dependent (10 mM etha-
nol 39 ± 8% inhibition, n = 4 slices). Since the pattern of
network activity is controlled, ethanol must directly inhibit
adenosine release.
Since ethanol can enhance basal A1-receptor activation,
this could inhibit activity-dependent adenosine release (see
Wall and Dale, 2013). To test this possibility, adenosine
release was evoked in the presence of 8CPT, an A1 receptor
antagonist (2 μM, Figure 6B, C). The mean inhibition by
ethanol in 8CPT (60.6 ± 10%, n = 7) was not signiﬁcantly
(P < 0.05, unpaired t-test) different from control inhibition.
Figure 5
Ethanol applied during established seizures inhibits adenosine release and changes network activity. (A) Traces from an adenosine biosensor (null
subtracted), data deconvolved (decon, time constant 250 s) and network activity recorded with an extracellular electrode (ext). Ethanol (50 mM)
inhibited adenosine release and changed the pattern of activity. Electrical stimulation (stim) released a greater amount of adenosine once ethanol
was washed out. (B) Portions of the extracellular recording from (A, dotted boxes) illustrate how ethanol changed the pattern of activity. (C) Trace
from an ADO biosensor (null subtracted) with network activity (ext) from a different hippocampal slice. Electrical stimulation (50 stimuli, 20 Hz at
arrows) during a period of low network activity evoked adenosine release, which was reversibly inhibited by ethanol (50 mM).
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Thus, an increase in activation of A1 receptors is not a major
mechanism for the inhibition of activity-dependent adeno-
sine release. Electrically stimulated adenosine release in the
hippocampus is glutamate receptor-dependent with both
AMPA and NMDA receptors involved (Wall and Dale, 2013).
Ethanol could reduce activity-dependent adenosine release
Figure 6
Ethanol inhibits electrically stimulated adenosine release. (A) Graph summarizing effects of 50 mM ethanol on electrically stimulated adenosine
release [open circles, individual experiments; ﬁlled circles, mean data (n = 15)]. Inset, adenosine biosensor traces from an individual experiment
in control, ethanol and following wash. (B) Stimulated adenosine release-events recorded with an adenosine biosensor in the presence of the A1
receptor antagonist 8CPT. Ethanol (50 mM) still inhibited adenosine release, an effect, which was reversed in wash. (C) Bar chart summarizing
data from seven recordings where ethanol (50 mM) signiﬁcantly (*P < 0.05) decreased adenosine release in the presence of 8CPT. (D) fEPSPs
(from the start of trains of stimuli used to evoke adenosine release) were recorded at the same time as biosensor measurements. Although ethanol
reversibly abolished adenosine release-events, the fEPSPs increased in amplitude.
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by inhibiting glutamate release. This seemed unlikely as this
was not observed when we recorded fEPSPs where the inhib-
itory effects of ethanol were blocked by 8CPT. However, to
conﬁrm it, we recorded fEPSPs simultaneously with biosen-
sor measurements of the stimulated adenosine release
(n = 4). There was no clear relationship between the
inhibition of adenosine release and the effects of ethanol
on fEPSPs. For example in Figure 6D, although the ampli-
tude of fEPSPs was increased in ethanol (~75%), adenosine
release was abolished, an effect that was reversed upon
wash. Thus, the ethanol-mediated inhibition of activity-
dependent adenosine release appears independent of an
effect on glutamate release.
Ethanol preferentially blocks a slow component
of adenosine release
We observed that in many biosensor recordings, the low
amplitude adenosine waveform that persisted in 50 mM
ethanol had a different time course to the control waveforms
(e.g. see inset in Figure 6A). To examine this further, we used a
lower concentration of ethanol (10 mM), which had less ef-
fect on the amplitude of the biosensor signal, so we could
measure the kinetics of the adenosine-waveform more
accurately (Figure 7A). We found that that the decay of the
adenosine waveforms in ethanol was signiﬁcantly faster than
those in control (Figure 7B). We also examined the slices
where ethanol had no signiﬁcant effect on adenosine release
and found that in these slices, the adenosine waveforms
had a signiﬁcantly faster decay than in slices where ethanol
produced inhibition (Figure 7C, mean time constant 75 ± 10
vs. 155 ± 20 s, n = 5). These data suggest that ethanol preferen-
tially blocks a slow component of stimulated-adenosine
release. It also suggests that this component can be absent
in some slices where ethanol has little or no effect on
activity-dependent adenosine release.
NMDA receptors play a role in the actions of
ethanol
We have previously shown that electrically stimulated
hippocampal adenosine release is both AMPA and NMDA
receptor-dependent (Wall and Dale, 2013). Blocking NMDA
receptors reduces adenosine release by on average ~70%, with
little effect in some slices but complete block of release in
others (Wall and Dale, 2013). These are similar to the variable
effects that ethanol produces on electrically stimulated
adenosine release. Furthermore, it has been reported that
ethanol can block NMDA receptors (Lovinger et al., 1990),
and thus, this could be the mechanism of how ethanol
reduces adenosine release. To investigate this further, we
compared the effects of ethanol (50 mM) with the effects of
blocking NMDA receptors with the antagonist L689560
(5 μM) on stimulated adenosine release in the same slices.
In ﬁve slices, both ethanol and L689560 abolished electrically
stimulated adenosine release (ethanol was ﬁrst applied,
washed and then L689560 was applied). In a further four
slices, application of L689560 partially blocked stimulated
adenosine release (mean inhibition 61 ± 5%), leaving a
component with a faster decay (Figure 7D) that is very similar
to the effects that are observed with ethanol application
(Figure 7A, B). To test whether the effects of ethanol can be
accounted for by the block of NMDA receptors, we attempted
to occlude the effects of ethanol on stimulated adenosine re-
lease, by ﬁrst blocking NMDA receptors with the antagonist
L689560. In 10 slices, NMDA receptors were blocked (5 μM
L689560) that partially reduced the electrically stimulated
release of adenosine, and then ethanol (50 mM) was applied.
In six out of 10 slices, ethanol had no signiﬁcant (P > 0.05.
one-way ANOVA) effect on adenosine release consistent with
the inhibitory effects of ethanol occurring via the block of
NMDA receptors (Figure 7E). However, in four out of the 10
slices, ethanol still abolished the stimulated adenosine
Figure 7
Ethanol inhibits an NMDA receptor-dependent component of
adenosine release. (A) Superimposed and normalized adenosine
waveforms in control and in 10 mM ethanol. The waveform in
ethanol has a faster decay than in control (decay ﬁtted with single
exponentials, τ = 220 and 69 s). Inset, waveforms from (A)
superimposed but not normalized. (B) Graph summarizing the
mean time constant for exponentials ﬁtted to the decay of ADO
biosensor waveforms in control and in ethanol (n = 5). (C) Example
of an ADO biosensor trace (with null subtracted) where ethanol
(50 mM) had no signiﬁcant effect on stimulated-adenosine release.
Inset, expanded adenosine release event taken (*) with the decay
ﬁtted with a single exponential (τ = 62 s). (D) Adenosine waveforms
in control and following application of L689560 (5 μM) to block
NMDA receptors. The waveform decays are ﬁtted with single
exponentials (control τ = 320 s; L689,560 τ = 95 s). (E) Following
L689,560 (5 μM) application, ethanol (50 mM) had little effect
(mean reduction 7 ± 5%, no different to normal run down) on
the stimulated release of adenosine.
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release. This suggests that ethanol can have additional effects,
as well as blocking NMDA receptors, that contribute to the
inhibition of adenosine release.
Low concentrations of ethanol modify
adenosine release and seizure activity
In most experiments, we have used 50 mM ethanol, which is
a concentration that can be measured in the blood stream of
heavy drinkers (reviewed in Harrison et al., 2017). We were
interested in the effects that lower concentrations of ethanol
could have on adenosine release. Thus, we used 10–15 mM
ethanol, a concentration of ethanol found with social drink-
ing (Harrison et al., 2017). At this concentration, ethanol
could still inhibit stimulated adenosine release (~50%;
Figures 7A and 8A, n = ﬁve out of 8 slices) without inducing
changes in the basal concentration of adenosine (Figure 8A).
We then investigated the effect of 10–15 mM ethanol on
Figure 8
Low concentrations of ethanol reduce adenosine release and modify seizure activity. (A) Trace from an ADO biosensor (null subtracted).
Adenosine release was stimulated (20 Hz 50 stimuli, at asterisks). Ethanol (10 mM) inhibited adenosine release but did not increase the baseline
current. Higher concentrations abolished adenosine release but also increased the extracellular concentration of adenosine. These effects were
reversible upon wash. (B) Traces are shown from an adenosine biosensor (null subtracted), these data are deconvolved (time constant 250 s),
and the extracellular activity was extracted from the biosensor. Ethanol (10 mM) reduced adenosine release and the interval between bursts.
(C,D) Ethanol (12 mM) either changed extracellular activity (C) or had no effect (D).
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seizure activity. Pre-incubation with ethanol (10–15 mM) sig-
niﬁcantly shortened the latency to activity onset (from
166 ± 6 to 120 ± 15 s, P < 0.05, unpaired t-test, n = 6) consis-
tent with a reduction in adenosine release suppressing activ-
ity. In some slices, ethanol also reduced activity-dependent
adenosine release (Figure 8B, mean inhibition 55 ± 15%,
n = 4) and reduced both the interval between bursts and burst
duration (Figure 8B, C). In other slices, it had little effect on
either adenosine release or the network activity (Figure 8D,
n = 4). Thus, even at low concentrations, ethanol can modu-
late adenosine release leading to changes in network activity.
Discussion
Using biosensor measurements and electrophysiology, we
have investigated the effects that ethanol has on adenosine
release and network activity in the hippocampus. Perhaps
not surprisingly, the effects of ethanol were complex and
variable. There were however two clear results: (i) ethanol
can alter the basal extracellular concentration of adenosine
leading to changes in A1 receptor activation and (ii) ethanol
can inhibit activity-dependent adenosine release. The net
balance between these effects could potentially supress activ-
ity, enhance activity or have no signiﬁcant effect (as observed
in our fEPSP recordings and that reported by Diao and
Dunwiddie, 1996). These variable effects on adenosine
signalling probably contribute to the inconsistent effects of
ethanol that have been reported in the literature.
Ethanol has minor effects on microelectrode
biosensor properties
This is the ﬁrst study to use microelectrode biosensors to
directly investigate the effects of ethanol on adenosine
release and its extracellular concentration. We found that
ethanol had no inhibitory effect on adenosine biosensor
sensitivity. This is supported by information from the en-
zyme database BRENDA (Placzek et al., 2017), which does
not list ethanol as an inhibitor of any of the adenosine-
sensing enzymes. Ethanol does induce a current on both the
ADO biosensor and the null sensor, which is consistent with
the direct oxidation of ethanol, with the liberation of
electrons to produce the sensor current. However, the
currents were small, illustrating the effectiveness of the
screening layer and were linearly related to ethanol concen-
tration and can be removed by subtraction. Thus, microelec-
trode biosensors are a useful tool to study the effects of
ethanol on brain function.
Ethanol modulates the background
extracellular activation of adenosine receptors
Acute ethanol exposure can increase the basal activation of
A1 receptors (reducing fEPSP slope), have no net effect or
decrease basal A1 receptor activation (increasing fEPSP slope).
These inconsistent effects on basal synaptic transmission
have also been reported by Diao and Dunwiddie (1996). The
enhanced A1 receptor activation was produced by an increase
in the extracellular concentration of adenosine, which was
rapid and dependent on the concentration of ethanol
(threshold ~20 mM). The precise mechanism for this effect
remains unclear. It does not appear to be glutamate
receptor-dependent (unlike electrically stimulated adenosine
release) and does not appear to result from ENT inhibition. It
has been reported that acute infusion of ethanol into the
hypothalamus leads to a rapid and direct release of adenosine
in vivo (Sharma et al., 2010). The fall in the increase in
extracellular adenosine concentration with repeated ethanol
applications suggests either rapid tolerance or depletion of
the intracellular adenosine pool (Pearson et al., 2001; Klyuch
et al., 2011). It would be interesting to see if this effect of
ethanol is still observed in tissue from naïve animals.
Ethanol can also reduce the basal activation of A1
receptors, enhancing synaptic transmission. The mechanism
for this could be a reduction in activity-dependent adenosine
release, although a clear fall in ADO biosensor baseline was
not observed. In some slices, the A1 receptor basal activation
was high, probably reﬂecting increased network activity. It
is possible that this network activity is highly localized
(around extracellular electrode), and thus, changes in
adenosine concentration will not be detected (Wall and Rich-
ardson, 2015). The fall in basal A1 receptor activation could
also result from ethanol inhibiting NTPDases (Rico et al.,
2008) reducing conversion of ATP to adenosine.
Ethanol inhibits activity-dependent adenosine
release
During epileptiform activity, the amount of adenosine
released into the extracellular space was reduced by ethanol.
By controlling the pattern of network activity, we showed
that the reduction in adenosine release can occur indepen-
dently of network activity changes. Ethanol inhibits NMDA
receptors (Lovinger et al., 1990; Wirkner et al., 1999;
Möykkynen and Korpi, 2012) with 25 mM having a marked
effect (Lovinger et al., 1990). It has previously been shown
that NMDA receptor activation in the hippocampus releases
adenosine (Manzoni et al., 1994; Wall and Dale, 2013), and
blocking NMDA receptors markedly inhibits stimulated
adenosine release (Wall and Dale, 2013). Experiments where
an NMDA receptor antagonist was used to occlude the effects
of ethanol on activity-dependent adenosine release were suc-
cessful in some slices but not in others. This suggests that
there are additional mechanisms for reducing adenosine re-
lease. One suchmechanism could be the depletion of internal
adenosine stores. The increase in the basal extracellular
concentration of adenosine could deplete stores of adenosine
so that there is less adenosine to be released by activity.
Pearson et al. (2001) showed that such a depletion of stores
can occur during ischaemia, and Klyuch et al. (2011) showed
that prolonged electrical stimulation depletes adenosine
stores that recover when stimulation stops. During seizure
activity, changes in the pattern of activity may also contrib-
ute to a reduction in adenosine release.
The effects of ethanol on adenosine signalling appear
contradictory: it can enhance the basal extracellular concen-
tration of adenosine but can also inhibit electrically stimu-
lated adenosine release and adenosine release during seizure
activity. A full explanation for this duality of ethanol effects
is lacking, but it appears that the effects occur via separate
mechanisms. It also appears that the effects on stimulate re-
lease occur with lower concentrations of ethanol than that
on the basal extracellular adenosine concentration.
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Actions of ethanol on network activity during
seizures
The effects of ethanol on network activity during seizures
were variable and depended on when the ethanol was ap-
plied. Both high and low concentrations of ethanol could
convert isolated bursts of activity into continuous activity.
The loss of activity-dependent adenosine release removes
the negative feedback provided by A1 receptor activation pro-
moting continuous activity. This is a similar to effects pro-
duced by A1 receptor antagonists. However, the other effects
of ethanol will also contribute to changes in activity such as
the enhancement of GABAA receptor activation. The inhibi-
tion of adenosine release could potentially make ethanol
pro-convulsant, but they are offset by an increase in basal
adenosine concentration, inhibition of NMDA receptors
and other effects such as the enhancement of GABA effects
(Harrison et al., 2017). Low concentrations of ethanol, which
may selectively reduce adenosine release, aremore likely to be
pro-convulsant, as there is less effect on GABA and NMDA re-
ceptors. This is supported by our observations that in some
slices, low concentrations of ethanol can reduce the latency
to seizure activity, lengthen bursts of activity and convert iso-
lated bursts of activity into continuous activity. However, the
effects were variable with no clear effects in around half of the
slices tested.
Conclusions
Do these data on the effects of acute ethanol exposure on
adenosine signalling allow us to extrapolate to human
epileptic patients and ethanol drinkers and provide advice
on ethanol drinking habits? It appears that low doses of
ethanol can be pro-convulsant as they inhibit adenosine
activity-dependent release and can enhance activity. It may
therefore be advisable for epileptics to avoid ethanol alto-
gether rather than having a small amount. Higher doses of
ethanol are anticonvulsant, supressing activity but there is
evidence that following the elimination of ethanol, seizure
threshold is diminished. The results from this study have to
be interpreted with caution as the tissue came from rats that
were ethanol naïve, and thus, the data may best reﬂect the
effect of ethanol on epileptic patients who are about to have
their ﬁrst alcoholic drink.
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